Triple negative breast cancer MDA-MB-231 cells, which are characterized as negative for estrogen receptor (ER), progesterone (PR), and epidermal growth factor receptor (EGFR or HER2), become indicated of invasive breast cancer as a consequence of poor prognosis and have a potential to become drug-resistant [19]. This evidence concerns the gene EGFR and triple-negative breast carcinoma.